<DOC>
	<DOCNO>NCT00777777</DOCNO>
	<brief_summary>Prospective , multi-center , randomize , control ( patient control ) trial external mesh device ( eSVS™ , Kips Bay Medical ) support saphenous vein graft coronary bypass graft surgery patient multi-vessel coronary heart disease .</brief_summary>
	<brief_title>The eSVS ( TM ) Mesh External Saphenous Vein Support Trial</brief_title>
	<detailed_description>The objective eSVS™ Mesh Saphenous Vein Support Trial prospectively evaluate clinical safety efficacy eSVS™ Mesh treatment Saphenous Vein Graft ( SVG ) Coronary artery bypass grafting ( CABG ) versus SVG CABG without eSVS™ Mesh . The eSVS™ Mesh External Saphenous Vein Support Trial prospective , multi-center , randomize , control trial enrol 120 patient multi-vessel coronary artery disease require SVG CABG Right Coronary Artery Circumflex Artery due atherosclerotic coronary artery disease . Patients serve control ( patient randomize either : 1 . SVG+eSVS™ Mesh Right Coronary Artery SVG Circumflex Artery 2 . SVG Right Coronary Artery SVG+eSVS™ Mesh Circumflex Artery ) . Clinical follow-up assessment consist physical exam , laboratory testing , medication review , adverse event monitoring enrol patient perform 30 day , 6 month 12 month . In addition , 12 month follow-up assessment include angiography . The investigational device evaluate clinical trial External Saphenous Vein Support device , eSVS™ Mesh . The eSVS™ Mesh extravascular prosthesis consist highly flexible , semi-compliant knit nitinol mesh tube place patient 's saphenous vein graft ( SVG ) coronary artery bypass grafting ( CABG ) . The eSVS™ Mesh design : - provide radial support vein prevent graft dilatation - reduce vein graft diameter closely match target coronary artery diameter - provide uniform lumen - improve blood flow characteristic - mitigate development intimal hyperplasia graft stenosis The eSVS™ Mesh compliance characteristic comparable native internal thoracic artery . Since eSVS™ Mesh vascular prosthesis make nitinol , highly kink resistant .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1. require onpump SVG CABG Right Coronary Artery Circumflex Artery due atherosclerotic coronary artery disease , ≥ 75 % stenosis vessel 2. appropriately size accessible target coronary artery , minimum diameter 1.5 mm lack calcification anastomotic site 3. able give inform write consent 4. ≥ 21 year age 1. appropriate target coronary vessel 2. discreet attachment SVG aorta possible ( nonconsecutive `` jump '' graft exclude ) 3. concomitant nonCABG cardiac procedure 4. prior peripheral vascular cardiac surgery 5. prior stroke 6. history atrial fibrillation 7. diffuse peripheral vascular disease 8. age &gt; 80 9 . LVEF &lt; 30 % time enrollment 10 . Insulindependent diabetes 11. concurrent participation another trial 12. concomitant lifethreatening disease likely limit life expectancy le 2 year 13. contraindication onpump CABG cardioplegic arrest ( calcified aorta , calcified coronary , small target vessel ) 14. emergency CABG surgery 15. inability tolerate comply normal postsurgical drug regimen ( antiplatelet plus statin ) 16. take warfarin clopidogrel time surgery 17. inability comply require followup , include angiography image method 18. patient pregnant intend become pregnant next 12 month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>multi-vessel , therapy , surgery , CABG</keyword>
</DOC>